Skip to main content
. 2021 Apr 3;901:174082. doi: 10.1016/j.ejphar.2021.174082

Fig. 12.

Fig. 12

BE for the virtual hit compounds. The violet line shows the cut-off range for compound selection, (A) FDA approved compounds, (B) PubChem COVID-19 clinical trial compounds, (C) NPASS Database compounds, and (D) Maybridge Database compounds.